Abbott LaboratoriesABTNYSE
Loading
Gross Profit Over TimeExpanding
Percentile Rank100
3Y CAGR+3.3%
5Y CAGR+7.2%
Year-over-Year Change
Revenue minus cost of goods sold
3Y CAGR
+3.3%/yr
vs +9.0%/yr prior
5Y CAGR
+7.2%/yr
Recent deceleration
Acceleration
-5.7pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.4x
Solid growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $24.61B | +15.4% |
| 2024 | $21.32B | +6.4% |
| 2023 | $20.04B | -10.2% |
| 2022 | $22.32B | -3.8% |
| 2021 | $23.21B | +33.6% |
| 2020 | $17.38B | +4.1% |
| 2019 | $16.69B | +5.5% |
| 2018 | $15.82B | +21.1% |
| 2017 | $13.07B | +16.2% |
| 2016 | $11.24B | - |